Scholars Central

Research articlePublished 2021

Fighting the Rising Spectre of Tough Bugs in Tough Clinical Scenario: A Ten Year Experience from a Hemato-Oncology Centre in Tertiary Health Care Facility in North India

Authors: Himani Dhingra, Manas Kalra, Leena Mendiratta, Hena Butta, Raman Sardana, Amita Mahajan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Infections with multi drug resistant (MDR) organisms pose a major challenge in achieving optimal success in pediatric oncology patients. Aim: We aimed to study the evolving blood stream flora, its antibiotic resistance pattern and impact of a rigorous antibiotic stewardship programme at our center. Materials and Methods: A 10 year retrospective analysis was performed on suspected episodes of septicemia in pediatric oncology patients. Blood culture isolates, resistance patterns and clinical outcome of corresponding septic episodes were studied over two time periods- TP1 (2007-2013) and TP2 (2014-2018). Results: Of 1423 blood culture samples, 285 were positive. TP1 showed predominant growth of Gram negative bacteria (GNB-48.5%) and TP2 showed isolates that were mainly Gram positive cocci (GPC-50.3%) reflecting increased use of central lines. Coagulase negative Staphylococcus (CoNS) was the commonest GPC and E. coli was the most common GNB isolated in TP2. Cefaperazone sulbactum monotherapy was used as the first line antimicrobial for neutropenic fever in our unit in TP2 and it was observed that 72% of the GNB were sensitive to this drug. In the comparative analysis of TP2 vs TP1, it was observed that the GNB isolates showed increasing resistance to Carbapenems. Interestingly, a declining trend of resistance was observed with Chloramphenicol for both GNB/GPC. Flouroquinolone resistance has consistently been high over the two time periods. No in vitro resistance was identified to Glycopeptides and Colistin over TP1 and TP2. Mortality rates in children blood culture positivity remained the same across TP1 and TP2 (2.2 vs. 2.6%). Conclusion: Despite rising incidence of MDR bacteria, a rigorous antibiotic stewardship programme helps maintain good outcomes in pediatric oncology patients with sepsis. Early diagnosis, judicious use of antibiotics and de-escalation after initial stabilization may help. Innovative strategies to fight drug resistance are being evolved.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases and Treatment
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Himani Dhingra”
  • BylineArticles whose byline prints “Manas Kalra”
  • BylineArticles whose byline prints “Leena Mendiratta”
  • BylineArticles whose byline prints “Hena Butta”
  • BylineArticles whose byline prints “Raman Sardana”
  • BylineArticles whose byline prints “Amita Mahajan”